Literature DB >> 6979444

The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens.

A P Johnstone, R E Millard, L Hudson.   

Abstract

The proliferative response of lymphocytes from patients with chronic lymphocytic leukaemia (CLL) to the polyclonal activators, phytohaemagglutinin (PHA) and pokeweed mitogen (PWM) correlates inversely with the logarithm of the circulating lymphocyte concentration in vivo (P less than 0.001). This suggests that the response is due primarily to residual normal cells in the circulation. In support of this postulate, dilution of normal cells reproduced the effect and also induced a delayed response to PHA, which is found frequently with CLL lymphocytes. A combination of autoradiography and immunofluorescence microscopy identified both B and T cells in the responding population in similar proportions from both normal and CLL donors. These data demonstrate that the 3H-thymidine assay used in most mitogenic studies is not suitable alone for investigating the functional capacity of leukaemic lymphocytes in CLL and other diseases involving a gross perturbation of lymphocyte populations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979444      PMCID: PMC1536433     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  Studies of correlation of lymphocyte response to phytohemagglutinin with the clinical and immunologic status in chronic lymphocytic leukemia.

Authors:  T Han
Journal:  Cancer       Date:  1973-02       Impact factor: 6.860

3.  Evidence for transformation of human B lymphocytes by PHA.

Authors:  B Phillips; I M Roitt
Journal:  Nat New Biol       Date:  1973-02-21

4.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

5.  Response of lymphocytes in chronic lymphocytic leukaemia to plant mitogens.

Authors:  J L Smith; D C Cowling; C R Barker
Journal:  Lancet       Date:  1972-01-29       Impact factor: 79.321

6.  The delayed response of c0ronic lymphocytic leukemia lymphocytes to phytohemagglutinin in vitro.

Authors:  K Havemann; A D Rubin
Journal:  Proc Soc Exp Biol Med       Date:  1968-03

7.  Effects of phytohemagglutinin and isoproterenol on DNA synthesis in lymphocytes from normal donors and patients with chronic lymphocytic leukemia.

Authors:  C W Abell; C W Kamp; L D Johnson
Journal:  Cancer Res       Date:  1970-03       Impact factor: 12.701

8.  'Delayed' peaks of DNA synthesis in phytohemagglutinin-stimulated human leucocyte cultures.

Authors:  J H Robbins; W R Levis
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

9.  Studies of the delayed response of phytohemagglutinin (PHA) stimulated lymphocytes in 25 chronic lymphatic leukemia patients before and during therapy.

Authors:  B A Bouroncle; K P Clausen; J F Aschenbrand
Journal:  Blood       Date:  1969-08       Impact factor: 22.113

10.  Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.

Authors:  V C Maino; J T Kurnick; R T Kubo; H M Grey
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

View more
  1 in total

1.  The inhibition of DNA synthesis in chronic lymphocytic leukaemia cells by chlorambucil in vitro.

Authors:  D P Bentley; J A Blackmore
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.